Abstract
2/2017
vol. 104
Case report
Pseudoporphyria secondary to renal failure
Dermatol Rev/Przegl Dermatol 2017, 104, 122–127
Online publish date: 2017/04/28
Introduction. Pseudoporphyria is a rare disease associated with chronic renal failure. Symptoms of pseudoporphyria may develop in response to UV exposure and medications. The literature reports cases of pseudoporphyria in patients infected with hepatis C virus, HIV and undergoing dialysis therapy.
Objective. Presentation of the case of a patient with pseudoporphyria and uraemic pruritus, and overview of therapeutic management.
Case report. A 64-year-old male patient, who had been on dialysis for chronic renal failure secondary to type 2 diabetes for the past 11 years, presented with tense bullae located on sun-exposed skin which had persisted for the previous 5 months. The patient was diagnosed with pseudoporphyria, and treatment was prescribed including N-acetylcysteine, chloroquine, paroxetine and mianserin. An improvement in the patient’s clinical condition and a regression of pruritus were achieved.
Conclusions. Patients with renal failure may develop symptoms of pseudoporphyria requiring differentiation from porphyria cutanea tarda.
Objective. Presentation of the case of a patient with pseudoporphyria and uraemic pruritus, and overview of therapeutic management.
Case report. A 64-year-old male patient, who had been on dialysis for chronic renal failure secondary to type 2 diabetes for the past 11 years, presented with tense bullae located on sun-exposed skin which had persisted for the previous 5 months. The patient was diagnosed with pseudoporphyria, and treatment was prescribed including N-acetylcysteine, chloroquine, paroxetine and mianserin. An improvement in the patient’s clinical condition and a regression of pruritus were achieved.
Conclusions. Patients with renal failure may develop symptoms of pseudoporphyria requiring differentiation from porphyria cutanea tarda.
Keywords
dialysis therapy, pseudoporphyria, chloroquine, renal failure, porphyria cutanea tarda
Coverage in
Integrated with


